Investment Rating - The report maintains a "Buy" rating for the company, with target prices set at 15.2forXPEV.US(potentialupsideof2215.2 for XPEV.US (potential upside of 22%) and HKD 59.3 for 9868.HK (potential upside of 18%) [1][6]. Core Insights - The company is entering a strong product cycle, with expected vehicle deliveries reaching 30,000 units in November, supported by strong order performance for models M03 and P7+. This positions the company for significant sales growth in 2024 and 2025, with revised sales forecasts of 188,000 units and 400,000 units respectively [1][2]. - The automotive gross margin has shown continuous improvement, reaching 8.6% in Q3 2024, benefiting from product mix enhancements and supply chain cost reductions. The company anticipates a 21% year-over-year revenue growth in Q4 2024 [2][4]. - The company plans to launch four new models and several refreshed versions next year, aiming to sustain sales growth. Additionally, overseas sales have increased by approximately 70% quarter-over-quarter, contributing to 15% of total sales [2][3]. Financial Performance and Forecast - Revenue projections for the company are as follows: RMB 40.53 billion in 2024, RMB 74.5 billion in 2025, and RMB 140.165 billion in 2026, with corresponding year-over-year growth rates of 32%, 84%, and 88% respectively [4][16]. - The gross margin is expected to improve to 14.2% in 2024, 15.6% in 2025, and 16.9% in 2026, reflecting the positive impact of new platform models [4][16]. - The company reported a net loss of RMB 18.5 billion in Q3 2024, although this represents a significant year-over-year decrease [2][4]. Valuation - The report employs a sum-of-the-parts valuation method, assigning a sales multiple of 1.3x for automotive sales and 2.1x for services and other revenues, leading to a target price of 15.2forXPEV.US(potentialupsideof2215.2 for XPEV.US and HKD 59.3 for 9868.HK [3][19].
R1